How Weight Loss Drugs Are Reshaping What We Eat And Drink episode artwork

EPISODE · Jun 8, 2026 · 20 MIN

How Weight Loss Drugs Are Reshaping What We Eat And Drink

from Beer In Front · host Dave Zalatoris

What happens when millions of people simply stop wanting that second beer? In this episode of Beer In Front, I take a deep dive into the rapidly growing world of GLP-1 medications such as Ozempic, Wegovy, Mounjaro, and Zepbound—and explore how these drugs are reshaping the food and beverage industry. While most coverage focuses on weight loss, the bigger story may be changing consumer behavior. Research suggests GLP-1 medications don't just reduce appetite, they may also reduce cravings for alcohol, snacks, and other highly rewarding foods by affecting the brain's dopamine reward system. Why GLP-1 users are drinking significantly less alcoholNew research showing dramatic reductions in alcohol cravingsHow wine, beer, and spirits are being affected differentlyWhy bars and restaurants are seeing smaller checks and fewer repeat drink ordersThe projected $30-$55 billion impact on the food and beverage industryHow grocery shopping habits are changingThe opportunities for premium alcohol, craft beverages, and non-alcoholic alternativesWhy GLP-1 medications could become an important tool in treating alcohol use disorderWhat breweries, bars, restaurants, and food companies need to do to adaptAs adoption continues to grow and new oral versions of these medications reach the market, the effects on consumer spending and consumption habits may only accelerate.Whether you're in the beer business, restaurant industry, food manufacturing, or simply curious about how emerging health trends shape the economy, this episode explores one of the most important consumer shifts happening today.Statistic Sources1 in 8 U.S. adults currently on a GLP-1 drug KFF Health Tracking Poll, Nov 2025Up to 75% potential reduction in alcohol consumption Morgan Stanley 25% of GLP-1 users stopped drinking entirely Morgan Stanley41% reduction in daily drinking (clinical trial) JAMA Psychiatry2025 Wine down 52%, beer 43%, spirits 40% EY-Parthenon Survey10% of adults = 50% of all alcohol sold U.S. alcohol consumption data$30–55B projected F&B revenue loss by 2030–34 J.P. MorganFeb 2026 23% of households contain a GLP-1 user CNBC / industry data2026 Dinner traffic down 6% among regular users Restaurant industry analysis, 2026Become a supporter of this podcast: https://www.spreaker.com/podcast/beer-in-front--5704447/support.Beer Media Group

What happens when millions of people simply stop wanting that second beer? In this episode of Beer In Front, I take a deep dive into the rapidly growing world of GLP-1 medications such as Ozempic, Wegovy, Mounjaro, and Zepbound—and explore how these drugs are reshaping the food and beverage industry. While most coverage focuses on weight loss, the bigger story may be changing consumer behavior. Research suggests GLP-1 medications don't just reduce appetite, they may also reduce cravings for alcohol, snacks, and other highly rewarding foods by affecting the brain's dopamine reward system. Why GLP-1 users are drinking significantly less alcoholNew research showing dramatic reductions in alcohol cravingsHow wine, beer, and spirits are being affected differentlyWhy bars and restaurants are seeing smaller checks and fewer repeat drink ordersThe projected $30-$55 billion impact on the food and beverage industryHow grocery shopping habits are changingThe opportunities for premium alcohol, craft beverages, and non-alcoholic alternativesWhy GLP-1 medications could become an important tool in treating alcohol use disorderWhat breweries, bars, restaurants, and food companies need to do to adaptAs adoption continues to grow and new oral versions of these medications reach the market, the effects on consumer spending and consumption habits may only accelerate.Whether you're in the beer business, restaurant industry, food manufacturing, or simply curious about how emerging health trends shape the economy, this episode explores one of the most important consumer shifts happening today.Statistic Sources1 in 8 U.S. adults currently on a GLP-1 drug KFF Health Tracking Poll, Nov 2025Up to 75% potential reduction in alcohol consumption Morgan Stanley 25% of GLP-1 users stopped drinking entirely Morgan Stanley41% reduction in daily drinking (clinical trial) JAMA Psychiatry2025 Wine down 52%, beer 43%, spirits 40% EY-Parthenon Survey10% of adults = 50% of all alcohol sold U.S. alcohol consumption data$30–55B projected F&B revenue loss by 2030–34 J.P. MorganFeb 2026 23% of households contain a GLP-1 user CNBC / industry data2026 Dinner traffic down 6% among regular users Restaurant industry analysis, 2026Become a supporter of this podcast: https://www.spreaker.com/podcast/beer-in-front--5704447/support.Beer Media Group

NOW PLAYING

How Weight Loss Drugs Are Reshaping What We Eat And Drink

0:00 20:18

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Tales Of A Superstar DJ The Insomniac Spun seemingly out of nowhere from her complacent life in the corporate world, turned seemingly overnight from 16-Hour shift work and into the life of a literally starving artist and working musician, The Protagonist navigates her supposed rise to fame and superstardom on a journey through spiritual awakening, coming-of-age, and intimate self-realization--guided by an omnipresent force and equipped with the power of love, magic, and music. {Enter The Multiverse.} [The Festival Project] The Festival Project, Inc.™ is a multidimensional multimedia platform which encompasses exploratory and artistic social personifications and expressions on cosmic theory, spirituality, growth, health & wellness, philosophy and theoretic dynamics in entertainment such as music, design, film, television, radio, dance and festival culture, art, fashion, literature, and science. The Festival Project™ and its subsidiary Non-Profit, The Collective Complex © aims to challenge modern artistic and philosop Explicit Bitcoin Is Dead Trey Carson Welcome to Bitcoin is Dead, the ultimate Bitcoin variety show where host Trey takes you on a journey through the ever-evolving world of Bitcoin. Each episode brings new personalities, fascinating locations, and insightful conversations with politicians, educators, and innovators shaping the future of Bitcoin. Whether you're a seasoned Bitcoiner or just starting your journey, tune in for thought-provoking discussions, unique perspectives, and a deep dive into the ideas and people driving the Bitcoin revolution. Explicit The Sacred +Profane Podcast nephtaragrace The Sacred + Profane Podcast is a provocative conversation dedicated to cementing a better future for all. We specialize in unpacking the nuances of what is considered sacred and profane, particularly focusing on sex, death, and all that pertains to the circle of life. Our aim in focusing on such ”taboo” subject matter is to demystify what is unconscious, bring to light what has been known for centuries as ”the occult,” and empower the rapid transformation that is occurring on the Planet. Explicit Northern Sass and Southern Class Tay and Ani Come sit in on girl talk with Tay and Ani as we discuss life in Texas, girl math, food, wine and roasting each other. Explicit

Frequently Asked Questions

How long is this episode of Beer In Front?

This episode is 20 minutes long.

When was this Beer In Front episode published?

This episode was published on June 8, 2026.

What is this episode about?

What happens when millions of people simply stop wanting that second beer? In this episode of Beer In Front, I take a deep dive into the rapidly growing world of GLP-1 medications such as Ozempic, Wegovy, Mounjaro, and Zepbound—and explore how these...

Can I download this Beer In Front episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!